Clinical Trial Update: Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2, head-to-head trial comparing telmisartan and perindopril in patients with mild-to-moderate Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Telmisartan (Telmisartan)
• perindopril (perindopril)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED